We did not, however, analyze in depth other cancer diagnoses that are considered not curable but for which low-cost, effective therapies with relatively few side effects are available in the region and recommended by NCCN—for example, stage IV prostate cancer and stage IV hormone receptor–positive breast cancer but also low-grade chronic lymphocytic leukemia. This evidence concerns the gene NR4A1 and prostate carcinoma.